News Daily News Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5 Todd Neale October 09, 2020
News Conference News ESC 2020 More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART Yael L. Maxwell September 08, 2020
News Conference News ESC 2020 New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials Caitlin E. Cox September 03, 2020
News Daily News Reduced-Dose Prasugrel Works Well in Older, Low-Weight ACS Patients Todd Neale July 21, 2020
News Conference News EuroPCR 2020 Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients Michael O'Riordan June 30, 2020
News Daily News Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis Yael L. Maxwell June 30, 2020
News Daily News Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI Yael L. Maxwell June 03, 2020
News Daily News Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published Michael O'Riordan April 27, 2020
News Conference News ACC 2020 TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients Todd Neale March 31, 2020
News Daily News Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS Yael L. Maxwell March 10, 2020
News Daily News Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events Shelley Wood January 20, 2020
News Daily News No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry Todd Neale January 15, 2020
News Conference News AHA 2019 Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT Yael L. Maxwell November 17, 2019
News Daily News Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis L.A. McKeown November 01, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2019 Shelley Wood October 01, 2019
News Opinion Off Script TCT 2019 Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall Kwan S. Lee September 29, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
News Daily News CMR May Help Evaluate Nonculprit Lesions in STEMI Patients Todd Neale September 19, 2019
News Conference News ESC 2019 Another Step Forward for Genotype-Guided Prescribing After PCI: POPular Genetics Yael L. Maxwell September 03, 2019
News Conference News ESC 2019 Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5 Shelley Wood September 01, 2019